Emerging apoptosis agonists for bladder cancer

Author： Protzel Chris Hakenberg Oliver W

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.14, Iss.4, 2009-12, pp. : 607-618

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging Immunotargets in Bladder Cancer

Current Drug Targets, Vol. 17, Iss. 7, 2016-06 ,pp. : 757-770

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for targeted therapy of bladder cancer

By Agarwal Piyush K Black Peter C McConkey David J Dinney Colin PN

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 3, 2007-09 ,pp. : 435-448

Informa Healthcare

Access to resources Recommend Favorite

Management of Bladder Cancer: Current and Emerging Strategies

By Agarwal Neeraj

Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. : 1173-1187

Adis International

Access to resources Recommend Favorite

Emerging adenosine receptor agonists

By Gao Zhan-Guo Jacobson Kenneth A

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 3, 2007-09 ,pp. : 479-492

Informa Healthcare

Access to resources Recommend Favorite

Bladder Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 1, 2009-01 ,pp. : 8-8

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite